ATOM
ATOM accelerates drug discovery by transforming how therapies move from concept to clinic. The core technology is a pre-clinical design and optimization platform that combines high-performance computing, diverse biological data, and emerging biotechnologies to enable rapid, integrated in silico and experimental workflows. It uses computation, data-driven modeling, and generative molecular design, with the ATOM Modeling Pipeline (AMPL) as an open-source, modular software framework for building and sharing models to advance in silico discovery. The platform integrates results from mechanistic simulations and human-relevant experimentation to generate and optimize new drug candidates faster and more reliably than traditional methods. The model targets pharmaceutical and biotech researchers seeking faster timelines and higher success rates in drug development.
ATOM
ATOM accelerates drug discovery by transforming how therapies move from concept to clinic. The core technology is a pre-clinical design and optimization platform that combines high-performance computing, diverse biological data, and emerging biotechnologies to enable rapid, integrated in silico and experimental workflows. It uses computation, data-driven modeling, and generative molecular design, with the ATOM Modeling Pipeline (AMPL) as an open-source, modular software framework for building and sharing models to advance in silico discovery. The platform integrates results from mechanistic simulations and human-relevant experimentation to generate and optimize new drug candidates faster and more reliably than traditional methods. The model targets pharmaceutical and biotech researchers seeking faster timelines and higher success rates in drug development.